BioCentury | Apr 28, 2014
Strategy

Shepherding growth

...complementary products could be considered competitive, such as Novartis' Sentinel milbemycin oxime/lufenuron and Elanco's Trifexis spinosad/milbemycin...
BioCentury | Nov 7, 2011
Clinical News

Natroba spinosad: Phase II data

...122 patients with active lice infestations showed that a single application of 0.5% or 0.9% Natroba...
...in Boston. Last January, FDA approved an NDA from SePRO's ParaPRO LLC subsidiary for Natroba spinosad...
...Carmel, Ind. Product: Natroba spinosad Business: Infectious Molecular target: NA Description: Topical formulation containing 0.9% spinosad...
BioCentury | Aug 22, 2011
Company News

Pernix Therapeutics, SePRO sales and marketing update

...SePRO's ParaPRO LLC subsidiary and Pernix launched ParaPRO's Natroba spinosad topical 0.9% in the U.S. to...
...and older. The wholesale acquisition cost is $219 for a 120 mL bottle. FDA approved Natroba...
...to co-promote the product. Eli Lilly and Co. (NYSE:LLY, Indianapolis, Ind.) licensed the active ingredient, spinosad...
BioCentury | Jan 24, 2011
Clinical News

Natroba spinosad regulatory update

...FDA approved an NDA from SePRO's ParaPRO LLC subsidiary for Natroba spinosad topical 0.9% to treat...
...the active ingredient spinosad to ParaPRO in 2002. SePRO Corp. , Carmel, Ind. Product: Natroba spinosad...
BioCentury | Jan 17, 2011
Company News

Pernix Therapeutics, SePRO deal

...co-promote Natroba spinosad topical 0.9% in the U.S. to treat head lice. An NDA for Natroba...
...this half if approved. Eli Lilly and Co. (NYSE:LLY, Indianapolis, Ind.) licensed the active ingredient spinosad...
BioCentury | Apr 12, 1999
Company News

Integrated Genomics, Dow AgroSciences deal

...produces Dow’s spinosad insect control product. Dow, which will use the information to improve the spinosad...
Items per page:
1 - 6 of 6